Bulletin

Roche

New clinical and real-world data for Roche’s Vabysmo at ASRS reveal improved outcomes for people with two leading causes of vision loss

July 20, 2023

Press Information Bureau

It is important for every policy to evolve, and learnings need to be taken into consideration to improve them, to achieve the goal of creating better health outcomes for the citizens of the country: Dr. Mansukh Mandaviya at Health Ministry 's Swasthya Chintan Shivir in Dehradun

July 14, 2023

Roche

Positive Phase III results for Roche’s OCREVUS (ocrelizumab) twice a year, 10-minute subcutaneous injection in patients with multiple sclerosis

July 13, 2023

Press Information Bureau

Union Minister for Health and Family Welfare Dr Mansukh Mandaviya to inaugurate Swasthya Chintan Shivir on 14th July, 2023 at Dehradun, Uttarakhand

July 12, 2023

WHO

JOINT NEWS RELEASE - 122 million more people pushed into hunger since 2019 due to multiple crises, reveals UN report

July 12, 2023

Roche

Four-year follow up data for Roche’s Evrysdi show continued increase in number of children with a severe form of spinal muscular atrophy (SMA) able to sit, stand and walk

June 30, 2023

WHO

First WHO guidance on snakebite treatments published

June 23, 2023

Roche

CHMP recommends Roche’s Evrysdi for babies under two months old with spinal muscular atrophy (SMA)

June 21, 2023

Press Information Bureau

Dr. V.K. Paul, Member, NITI Aayog delivers keynote address in Townhall session for the G20 Co-branded Event on Adolescent Health and Well-being

June 20, 2023

WHO

Women and girls hit hard by attacks on health in Sudan, UN agencies warn

June 20, 2023

Press Information Bureau

Union Health Minister Dr Mansukh Mandaviya chairs meeting with Central and State agencies to review preparedness for Flood Management ahead of monsoon season in Assam

June 17, 2023

Roche

FDA approves Roche’s Columvi, the first and only bispecific antibody with a fixed-duration treatment for people with relapsed or refractory diffuse large B-cell lymphoma

June 16, 2023

Roche

FDA approves Roche’s Columvi, the first and only bispecific antibody with a fixed-duration treatment for people with relapsed or refractory diffuse large B-cell lymphoma

June 16, 2023

WHO

IOC and WHO launch Let's Move campaign on Olympic Day to inspire and enable the world to move for better health

June 13, 2023

Roche

Roche awarded WHO prequalification for the cobas® HPV test, increasing access to cervical cancer screening tools in low and lower-middle income countries

June 13, 2023

WHO

Urgent action needed as acute malnutrition threatens the lives of millions of vulnerable children

June 12, 2023

< 1 … 38 39 40 41 42 43 44 45 46 … 94 >

Bulletin

New clinical and real-world data for Roche’s Vabysmo at ASRS reveal improved outcomes for people with two leading causes of vision loss

It is important for every policy to evolve, and learnings need to be taken into consideration to improve them, to achieve the goal of creating better health outcomes for the citizens of the country: Dr. Mansukh Mandaviya at Health Ministry 's Swasthya Chintan Shivir in Dehradun

Positive Phase III results for Roche’s OCREVUS (ocrelizumab) twice a year, 10-minute subcutaneous injection in patients with multiple sclerosis

Union Minister for Health and Family Welfare Dr Mansukh Mandaviya to inaugurate Swasthya Chintan Shivir on 14th July, 2023 at Dehradun, Uttarakhand

JOINT NEWS RELEASE - 122 million more people pushed into hunger since 2019 due to multiple crises, reveals UN report

Four-year follow up data for Roche’s Evrysdi show continued increase in number of children with a severe form of spinal muscular atrophy (SMA) able to sit, stand and walk

First WHO guidance on snakebite treatments published

CHMP recommends Roche’s Evrysdi for babies under two months old with spinal muscular atrophy (SMA)

Dr. V.K. Paul, Member, NITI Aayog delivers keynote address in Townhall session for the G20 Co-branded Event on Adolescent Health and Well-being

Women and girls hit hard by attacks on health in Sudan, UN agencies warn

Union Health Minister Dr Mansukh Mandaviya chairs meeting with Central and State agencies to review preparedness for Flood Management ahead of monsoon season in Assam

FDA approves Roche’s Columvi, the first and only bispecific antibody with a fixed-duration treatment for people with relapsed or refractory diffuse large B-cell lymphoma

FDA approves Roche’s Columvi, the first and only bispecific antibody with a fixed-duration treatment for people with relapsed or refractory diffuse large B-cell lymphoma

IOC and WHO launch Let's Move campaign on Olympic Day to inspire and enable the world to move for better health

Roche awarded WHO prequalification for the cobas® HPV test, increasing access to cervical cancer screening tools in low and lower-middle income countries

Urgent action needed as acute malnutrition threatens the lives of millions of vulnerable children

Company

Resources